Evidence map›Paper›PMID 26589787›Full record

ArticleItalian journal of pediatrics2015

The burden of bacteremia and invasive diseases in children aged less than five years with fever in Italy.

Chiara Azzari, Maria Moriondo, Pasquale Di Pietro, Cesare Di Bari, Massimo Resti, Francesco Mannelli, Susanna Esposito, Guido Castelli-Gattinara, Antonio Campa, Fernando Maria de Benedictis and 4 more

Open access · goldAbstract readMulticenter Study
In one paragraph

Article in Italian journal of pediatrics, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.9field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 12 citations in OpenAlex.

  1. Observational
  2. Article
  3. [The new 15-valent pneumococcal conjugate vaccine for the prevention ofJournal of preventive medicine and hygiene · 2023
    Article
  4. Review
  5. Article
  6. Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 12 institutions in 2 countries.

Chiara AzzariDivision of Pediatric Immunology, Department of Health Sciences, University of Florence and Anna Meyer Children's University Hospital, Florence, Italy. Chiara.azzari@unifi.it.
Maria MoriondoDivision of Pediatric Immunology, Department of Health Sciences, University of Florence and Anna Meyer Children's University Hospital, Florence, Italy. m.moriondo@meyer.it.
Pasquale Di PietroIstituto Giannina Gaslini, Ospedale Pediatrico IRCCS, Via Gerolamo Gaslini 5, 16148, Genoa, Italy. pasqualedipietro@ospedale-gaslini.ge.it.
Cesare Di BariAzienda Ospedaliera Universitaria, Policlinico Consorziale di Bari, Piazza Giulio Cesare 11, 70124, Bari, Italy. cesare.dibari@libero.it.
Massimo RestiAnna Meyer Children's University Hospital, Florence, Italy. m.resti@meyer.it.
Francesco MannelliAnna Meyer Children's University Hospital, Florence, Italy. mannelli.francesco@gmail.com.
Susanna EspositoPediatric Highly Intensive Care Unit, Università degli Studi di Milano, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy. susanna.esposito@unimi.it.
Guido Castelli-GattinaraPaediatric Division, Bambino Gesù Children Hospital, v. Aurelia Km.30, 00100 Palidoro, Rome, Italy. guido.castelli@opbg.net.
Antonio CampaOspedale Santobono, Via Fiore Mario 6, 80129, Naples, Italy. antoniocampa2014@libero.it.
Fernando Maria de BenedictisOspedale Gaspare Salesi, via F. Corridoni, 60120, Ancona, Italy. debenedictis@ospedaliriunti.marche.it.
Gianni BonaAzienda Ospedaliera Maggiore della Carita', Corso Mazzini, n. 18, Novara, 28100, Italy. gianni.bona@maggioreosp.novara.it.
Lisa ComarellaCROS NT, SRL, Via Germania 2, 37136, Verona, Italy. lisa.comarella@crosnt.com.
Katsiaryna HollGSK Vaccines, Avenue Fleming 3, 1300, Wavre, Belgium. katsiaryna.x.holl@gsk.com.
Federico MarchettiGSK Vaccines, Via A. Fleming 2, 37135, Verona, Italy. federico.e.marchetti@gsk.com.
Meyer Children's Hospital · ITAzienda Universitaria Ospedaliera Consorziale - Policlinico Bari · ITBambino Gesù Children's Hospital · ITFondazione Ospedale Salesi · ITGlaxoSmithKline (Belgium) · BEGlaxoSmithKline (Italy) · ITIstituti di Ricovero e Cura a Carattere Scientifico · ITSantobono Children's Hospital · ITUniversità degli Studi del Piemonte Orientale “Amedeo Avogadro” · ITUniversity of Florence · ITUniversity of Milan · ITUniversity of Verona · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundInvasive diseases (ID) caused by Streptococcus pneumoniae (S. pneumoniae), Haemophilus influenzae (H. influenzae), and Neisseria meningitidis are a major public health problem worldwide. Comprehensive data on the burden of bacteremia and ID in Italy, including data based on molecular techniques, are needed.

methodsWe conducted a prospective, multi-centre, hospital-based study (GSK study identifier: 111334) to assess the burden of bacteremia and ID among children less than five years old with a fever of 39 °C or greater. Study participation involved a single medical examination, collection of blood for polymerase chain reaction (PCR) and blood culture, and collection of an oropharyngeal swab for colonization analysis by PCR.

resultsBetween May 2008 and June 2009, 4536 patients were screened, 944 were selected and 920 were enrolled in the study. There were 225 clinical diagnoses of ID, 9.8 % (22) of which were bacteremic. A diagnosis of sepsis was made for 38 cases, 5.3 % (2) of which were bacteremic. Among the 629 non-ID diagnoses, 1.6 % (10) were bacteremic. Among the 34 bacteremic cases, the most common diagnoses were community-acquired pneumonia (15/34), pleural effusion (4/34) and meningitis (4/34). S. pneumoniae was the most frequently detected bacteria among bacteremic cases (29/34) followed by H. influenzae (3/34). Ninety percent (27/30) of bacteremic patients with oropharyngeal swab results were colonized with the studied bacterial pathogens compared to 46.1 % (402/872) of non-bacteremic cases (p < 0.001). PCV7 (7-valent pneumococcal conjugate vaccine) vaccination was reported for 55.9 % (19/34) of bacteremic cases. S. pneumoniae serotypes were non-vaccine serotypes in children who had been vaccinated. Mean duration of hospitalization was longer for bacteremic cases versus non-bacteremic cases (13.6 versus 5.8 days).

conclusionsThese results confirm that S. pneumoniae is one of the pathogens frequently responsible for invasive disease.

Indexed as

Cost of IllnessBacteremiaBacteriaChild, PreschoolCommunity-Acquired InfectionsDNA, BacterialFemaleFeverFollow-Up StudiesHospitalizationHumansIncidenceInfantItalyMalePolymerase Chain ReactionDNA, Bacterial

Identifiers

PMID26589787
PMCPMC4654905
OpenAlexW2174558954

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.